Cimin Long

Cimin Long


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
GDGeyan Duan
Geyan Duan
JLJianjun Li
Jianjun Li
YDYehui Duan
Yehui Duan
CZChangbing Zheng
Changbing Zheng
QGQiuping Guo
Qiuping Guo
CLCimin Long
Cimin Long
Iron is a trace element necessary for cell growth, development, and cellular homeostasis, but insufficient or excessive level of iron is toxic. Intracellularly, sufficient amounts of iron are required for mitochondria (the center of iron utilization) to maintain their normal physiologic function. Iron deficiency impairs mitochondrial metabolism and respiratory activity, while mitochondrial iron overload promotes ROS production during mitochondrial electron transport, thus promoting potential disease development. This review provides an overview of iron homeostasis, mitochondrial iron metabolism, and how mitochondrial iron imbalances-induced mitochondrial dysfunction contribute to diseases.

27 October 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
JXJuan Xu
Juan Xu
ZJZhen Jia
Zhen Jia
SXShu Xiao
Shu Xiao
CLCimin Long
Cimin Long
Leli WangLeli Wang
Leli Wang
Pathogenic enterotoxigenic Escherichia coli (ETEC) is a major cause of bacterial diarrhea in weaning piglets, which are vulnerable to changes in environment and feed. This study aimed to determine the effects of the ETEC challenge on piglet growth performance, diarrhea rate, jejunal microbial profile, jejunal morphology and goblet cell distribution. A total of 13 piglets from one litter were selected on postnatal day 21 and assigned to treatments with or without ETEC challenge at 1 × 108 CFUs, as ETEC group or control group, respectively. On postnatal day 28, samples were collected, followed by the detection of serum biochemical indexes and inflammatory indicators, HE staining, PAS staining and 16S rDNA gene amplicon sequencing. Results showed that the growth performance decreased, while the diarrhea rate increased for the ETEC group. The jejunum is the main segment of the injured intestine during the ETEC challenge. Compared with the control, the ETEC group displayed fewer goblet cells in the jejunum, where goblet cells are more distributed at the crypt and less distributed at the villus. In addition, ETEC piglets possessed higher abundances of the genus Desulfovibrio, genus Oxalobacter and genus Peptococus and lower abundances of the genus Prevotella 2, genus Flavonifractor and genus Blautra. In terms of alpha diversity, Chao 1 and observed features indexes were both increased for the ETEC group. Our study provides insights into jejunal histopathological impairment and microbial variation in response to ETEC infection for weaned piglets and is a valuable reference for researchers engaged in animal health research to select stress models.

2 September 2026 in Animals
Verified
Journal Article
Open access
PDF file
MCMengli Chen
Mengli Chen
张张张自成 自成 张
张自成 自成 张
LDLingling Du
Lingling Du
JYJin’E Yu
Jin’E Yu
HWHuiming Wang
Huiming Wang
YYYulong Yin
Yulong Yin
Polysaccharides are well known for their immunomodulatory properties and gut microbiota-regulating functions; however, their digestive stability and structure-dependent biological mechanisms remain poorly understood. This study investigated the in vitro enzymatic resistance and intestinal regulatory effects of a novel L-β-galactoglucan (Mw 400–520 kDa) derived from Agrobacterium sp. FN01, and further evaluated the in vivo effects of its corresponding crude fermentation product on growth performance and intestinal metabolism in pigs. Twenty-seven-day-old weaned piglets were randomly allocated to three treatments, with 16 pens per treatment and 13 piglets per pen, and fed basal diets supplemented with 0, 200, or 400 mg/kg of the crude product. The results showed that L-β-galactoglucan exhibited strong resistance to pancreatic α-amylase and glucoamylase under the tested in vitro conditions, with minimal release of low-molecular-weight oligosaccharides during hydrolysis. The 400 mg/kg crude product supplementation significantly improved growth performance, reduced the feed-to-gain ratio, and increased the apparent total tract digestibility of dry matter, crude protein, crude fat, and gross energy (p < 0.05). In addition, dietary supplementation with this crude product increased intestinal microbial diversity, enriched Halalkalibacter urbisdiaboli, and increased colonic concentrations of isobutyrate and isovalerate (p < 0.05). Functional metagenomic analysis further revealed enhanced microbial carbohydrate metabolism and energy metabolic pathways. In conclusion, under the in vitro conditions tested in this study, the novel L-β-galactoglucan exhibited resistance to the two tested enzymes. In the pig trial, this polysaccharide improved growth performance and nutrient utilization, and modulated the intestinal microbial composition. These observations suggest that the fermentation product may be promising for animal feeding applications.

30 July 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
HFHaohua Fu
Haohua Fu
NHNi Hengjia
Ni Hengjia
JWJianhui Wang
Jianhui Wang
TLTuo Leng
Tuo Leng
SWShusong Wu
Shusong Wu
YYYulong Yin
Yulong Yin
Gut lactic acid bacteria are emerging as potential targets for modulating host purine metabolism and alleviating hyperuricemia-related disorders. This study aimed to isolate purine-degrading lactic acid bacterial strains from porcine intestine and systematically evaluate their probiotic potential through both in vitro and in vivo approaches. A strain designated Pedio6-1 was isolated and identified as Pediococcus acidilactici based on 16S rRNA sequencing. In vitro assays demonstrated that P. acidilactici Pedio6-1 exhibited nearly complete adenine clearance (approaching 100%) and a total purine clearance rate of 30.73%, along with strong tolerance to acidic conditions, bile salts, and gastrointestinal enzymes. To further assess its in vivo efficacy, a high-fat diet-induced obese mouse model was employed. After 8 weeks of intervention, Pedio6-1 supplementation significantly reduced the final body weight and liver index, and markedly decreased hepatic guanine levels (p < 0.05), with a trend toward lower total purine content compared to the obese control group. Mechanistically, Pedio6-1 treatment significantly downregulated the hepatic mRNA expression of pro-inflammatory cytokines IL-1β and TLR4 (p < 0.05). Serum untargeted metabolomics revealed that Pedio6-1 treatment shifted the metabolic profile toward that of normal diet-fed mice, with differential pathways predominantly enriched in porphyrin metabolism and amino acid biosynthesis and metabolism. Notably, key metabolites with antioxidant and metabolic regulatory functions, including bilirubin, biliverdin, glutathione, citrate, L-cystathionine, and 4-pyridoxic acid, were significantly elevated following treatment, while N-acetylornithine and methylmalonate ester were decreased, indicating coordinated remodeling of oxidative stress defense, vitamin B6 homeostasis, and energy metabolism. Collectively, these findings indicate that Pedio6-1 not only possesses direct purine-degrading activity in vitro, but also ameliorates purine metabolic disturbances, inflammation, and oxidative stress in obese mice, likely through the modulation of porphyrin and amino acid metabolic pathways, highlighting its promise as a functional probiotic candidate for managing obesity-associated purine metabolic disorders.